[Induced labor with prostaglandin E2 gel after previous cesarean section].
With the rising rate of Caesarean sections, the number of pregnant patients with a previous Caesarean is increasing. Taking into consideration certain contraindications, it seems to be justified, to attempt induction of labour for vaginal delivery without major risk. However, the use of prostaglandins for cervical ripening in women with an unfavourable cervical status is particularly controversial. Thus, we analysed data from 385 trials of vaginal labour induction in a total of 522 patients with previous Caesarean section. Single or multiple cervical doses of prostaglandin-E2-gel had to be administered because of an unripe cervix (Bishop-score < 8) in 161 women for induction of labour for medical indications. 84.9% of those patients, in which labour induction was attempted after previous Caesarean section, delivered vaginally; 70% after two Caesareans. The highest success rates were seen after previous Caesarean for breech presentation, while there was still a vaginal delivery rate above 60% even after Caesarean for cephalopelvic disproportion or failure to progress. Maternal and foetal complications were seen with equal incidence in both study groups. Uterine ruptures totalling 0.5% were seen only in patients without cervical priming. Taking into consideration contraindications, intracervical application of PGE2-gel is a safe and effective method, even in patients after previous Caesarean section with clear advantages in case of an unripe cervix.
Behrens
O
O
Frauenklinik der Medizinischen Hochschule Hannover.
Goeschen
K
K
Jakob
H
H
Kauffels
W
W
D000282:Administration, Intravaginal; D000328:Adult; D002584:Cervix Uteri / Q000187:drug effects; D017604:Cesarean Section, Repeat; D000075202:Contraindications; D015232:Dinoprostone / Q000008:administration & dosage* / Q000009:adverse effects; D005113:Extraction, Obstetrical; D005260:Female; D005782:Gels; D006801:Humans; D007231:Infant, Newborn; D007751:Labor, Induced; D010121:Oxytocin / Q000008:administration & dosage; D011247:Pregnancy; D012307:Risk Factors; D014597:Uterine Rupture / Q000209:etiology; D016064:Vaginal Birth after Cesarean
D005782:Gels; D010121:Oxytocin; D015232:Dinoprostone
Geburtseinleitung mit Prostaglandin-E2-Gel bei Zustand nach Sectio.